BACKGROUND: Human papillomavirus (HPV)-positive cases of squamous cell carcinoma of the head and neck (SCCHN) have a much better disease outcome compared to SCCHN cases lacking HPV. Differences in microRNA (miRNA) expression may affect their clinical outcomes. METHODS: The miRNA expression was studied using microarrays and quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in HPV-16-positive and HPV-negative SCCHN cell lines. The role of HPV-16 E6 and E7 oncogenes in altering miRNA expression was investigated using human foreskin keratinocytes (HFKs). RESULTS: The miRNAs miR-363, miR-33, and miR-497 were upregulated, whereas miR-155, miR-181a, miR-181b, miR-29a, miR-218, miR-222, miR-221, and miR-142-5p were downregulated in HPV-positive cells compared to both HPV-negative SCCHN and normal oral keratinocytes. HPV-16 E6 oncogene altered miRNA expression in HFKs and in an HPV-16-positive cell line with E6 knockdown using siRNA. CONCLUSION: miRNAs differentially expressed in the presence of HPV-16 may provide biomarkers for SCCHN and identify cellular pathways targeted by this virus.
BACKGROUND:Human papillomavirus (HPV)-positive cases of squamous cell carcinoma of the head and neck (SCCHN) have a much better disease outcome compared to SCCHN cases lacking HPV. Differences in microRNA (miRNA) expression may affect their clinical outcomes. METHODS: The miRNA expression was studied using microarrays and quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in HPV-16-positive and HPV-negative SCCHN cell lines. The role of HPV-16 E6 and E7 oncogenes in altering miRNA expression was investigated using human foreskin keratinocytes (HFKs). RESULTS: The miRNAs miR-363, miR-33, and miR-497 were upregulated, whereas miR-155, miR-181a, miR-181b, miR-29a, miR-218, miR-222, miR-221, and miR-142-5p were downregulated in HPV-positive cells compared to both HPV-negative SCCHN and normal oral keratinocytes. HPV-16 E6 oncogene altered miRNA expression in HFKs and in an HPV-16-positive cell line with E6 knockdown using siRNA. CONCLUSION: miRNAs differentially expressed in the presence of HPV-16 may provide biomarkers for SCCHN and identify cellular pathways targeted by this virus.
Authors: Andreas Albers; Koji Abe; Jennifer Hunt; Jun Wang; Andres Lopez-Albaitero; Carsten Schaefer; William Gooding; Theresa L Whiteside; Soldano Ferrone; Albert DeLeo; Robert L Ferris Journal: Cancer Res Date: 2005-12-01 Impact factor: 12.701
Authors: Robert L Ferris; Ivan Martinez; Nicky Sirianni; Jun Wang; Andrés López-Albaitero; Susanne M Gollin; Jonas T Johnson; Saleem Khan Journal: Eur J Cancer Date: 2005-03 Impact factor: 9.162
Authors: K Chikamatsu; K Nakano; W J Storkus; E Appella; M T Lotze; T L Whiteside; A B DeLeo Journal: Clin Cancer Res Date: 1999-06 Impact factor: 12.531
Authors: R D Steenbergen; M A Hermsen; J M Walboomers; H Joenje; F Arwert; C J Meijer; P J Snijders Journal: Cancer Res Date: 1995-11-15 Impact factor: 12.701
Authors: Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce Journal: Proc Natl Acad Sci U S A Date: 2006-02-03 Impact factor: 11.205
Authors: Alice L Tang; Samantha J Hauff; John H Owen; Martin P Graham; Michael J Czerwinski; Jung Je Park; Heather Walline; Silvana Papagerakis; Jay Stoerker; Jonathan B McHugh; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E Prince Journal: Head Neck Date: 2011-12-13 Impact factor: 3.147
Authors: Ivan Martinez; Demian Cazalla; Laura L Almstead; Joan A Steitz; Daniel DiMaio Journal: Proc Natl Acad Sci U S A Date: 2010-12-27 Impact factor: 11.205
Authors: Jingbo Qiao; Sora Lee; Pritha Paul; Lauren Theiss; Joshua Tiao; Lan Qiao; Andrew Kong; Dai H Chung Journal: Surgery Date: 2013-06-24 Impact factor: 3.982
Authors: Ge Gao; Hiram A Gay; Rebecca D Chernock; Tian R Zhang; Jingqin Luo; Wade L Thorstad; James S Lewis; Xiaowei Wang Journal: Cancer Date: 2012-06-26 Impact factor: 6.860
Authors: Xinqi He; Yujuan Dong; Chung Wah Wu; Zengren Zhao; Simon S M Ng; Francis K L Chan; Joseph J Y Sung; Jun Yu Journal: Mol Med Date: 2013-02-08 Impact factor: 6.354